AtG Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

AtG Therapeutics General Information

Description

Developer of novel classes of drugs and biomarkers intended to prevent cancer therapeutic resistance. The company specializes in the discovery and development of new therapeutic technologies for cancer resistance, including biomarkers, drugs, and novel mechanisms, enabling health practitioners to improve the lives of patients affected by cancer therapeutic resistance.

Contact Information

Website
www.atgtx.com
Formerly Known As
Angiotheragnostics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hospital Duran i Reynals (3rd Floor)
  • Avenue Gran via 199
  • 08908 Barcelona
  • Spain
+34 932
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Hospital Duran i Reynals (3rd Floor)
  • Avenue Gran via 199
  • 08908 Barcelona
  • Spain
+34 932

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AtG Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator Completed Pre-Clinical Trials
3. Seed Round 21-Jul-2022 Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Pre-Clinical Trials
1. Spin-Off 01-Jan-2021 Completed Pre-Clinical Trials
To view AtG Therapeutics’s complete valuation and funding history, request access »

AtG Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AtG Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Blue Goose Capital Venture Capital Minority
Inveniam Group Corporation Minority
WA4STEAM Angel Group Minority
Biocat Accelerator/Incubator
To view AtG Therapeutics’s complete investors history, request access »

AtG Therapeutics FAQs

  • When was AtG Therapeutics founded?

    AtG Therapeutics was founded in 2021.

  • Where is AtG Therapeutics headquartered?

    AtG Therapeutics is headquartered in Barcelona, Spain.

  • What is the size of AtG Therapeutics?

    AtG Therapeutics has 9 total employees.

  • What industry is AtG Therapeutics in?

    AtG Therapeutics’s primary industry is Drug Discovery.

  • Is AtG Therapeutics a private or public company?

    AtG Therapeutics is a Private company.

  • What is AtG Therapeutics’s current revenue?

    The current revenue for AtG Therapeutics is .

  • How much funding has AtG Therapeutics raised over time?

    AtG Therapeutics has raised $721K.

  • Who are AtG Therapeutics’s investors?

    Blue Goose Capital, Inveniam Group, WA4STEAM, and Biocat have invested in AtG Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process